Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Bladder Neoplasms
Interventions
DRUG

Mycobacterial cell wall-DNA complex

8 mg MCC, intravesical - Induction Phase (6 weekly intravesical instillations) and Maintenance Phase (3 weekly instillations at months 3, 6, 12, 18 and 24).

Trial Locations (31)

10021

Memorial Sloan Kettering Cancer Centre, New York

12601

Hudson Valley Urology, Poughkeepsie

14642

University of Rochester Medical Center, Rochester

15212

Triangle Urology Group, Pittsburgh

21204

Chesapeake Urology Research Associates, Towson

21231

Johns Hopkins University, Baltimore

23502

Sentara Medical Group - Urology of Virginia, PC, Norfolk

32803

Winter Park Urology Associates P.A., Orlando

33136

University of Miami School of Medicine, Miami

37232

Vanderbilt University Medical Center, Nashville

47713

Welborn Clinic, Evansville

60637

The University of Chicago Hospitals, Chicago

75231

Urology Clinics of North Texas, P.A., Dallas

77030

M.D. Anderson Cancer Center, Houston

78229

Urology San Antonio Research, PA, San Antonio

85032

BCG Oncology, Phoenix

89148

Sheldon J Freedman, MD, Ltd, Las Vegas

92120

San Diego Clinical Trials, San Diego

06052

Connecticut Urological Research at Grove Hill, New Britain

08043

Delaware Valley Urology, LLC-Voorhees, Voorhees Township

V3V 1N1

Andreou Research, Surrey

V8T 5G1

Can-Med Clinical Research, Victoria

V8V 3N1

Dr. Steinhoff Clinical Research, Victoria

K7L 3J7

Centre for Applied Urological Research, Kingston

N6A 5W9

London Health Sciences Centre, London

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

M5G 2M9

University Health Network / Princess Margaret Hospital, Toronto

M6A 3B5

The Male Health Center, Toronto

H2X 3J4

Centre Hospitalier de l'Universite de Montreal, Montreal

H3T 1E2

Jewish General Hospital, Montreal

G1R 2J6

Centre de Recherche du CHUQ, Québec

Sponsors
All Listed Sponsors
lead

Bioniche Life Sciences Inc.

INDUSTRY